Search
for

    Sort by

    Community Join

    120-129 / 129 results

      community The "I just want hair until im 30" cope.

      in Chat  221 upvotes 3 months ago
      Participants want to maintain hair until at least age 30, using treatments like finasteride, dutasteride, and minoxidil. Hair loss remains a concern, with some considering hair transplants.
      [object Object]

      community Why anecdotal evidence is so valued around here?

      in Chat  18 upvotes 9 months ago
      The conversation discusses why personal stories about hair loss treatments like Minoxidil and finasteride are often taken more seriously than scientific evidence in certain forums. People tend to believe what they want and use others' experiences to support their own views on treatment effectiveness and side effects.

      community Why don’t people just just DUT instead of FIN?

      in Finasteride/Dutasteride  48 upvotes 11 months ago
      The conversation discusses the use of dutasteride (DUT) versus finasteride (FIN) for hair loss treatment, with some users preferring DUT for its effectiveness while others choose FIN due to its approval status, better long-term data, and lower risk of side effects. Users share personal experiences with both medications, including side effects and effectiveness.

      community I hate it when people write off your hairloss info because “you’re not a doctor.”

      in Treatment  76 upvotes 1 year ago
      A user shared their frustration about their cousin's refusal to take their advice on using finasteride for aggressive hair loss, despite the cousin's desperation and current use of minoxidil and consideration of PRP injections. The user, who has done extensive research, suggested the cousin needs a 5ar inhibitor, but the cousin dismisses the advice because the user isn't a doctor.
      [object Object]

      community Binding affinity of pyrilutamide!

      in Update  170 upvotes 2 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.